Tri-Methyl-Histone H4 (Lys59) Antibody

What is the Tri-Methyl-Histone H4 (Lys59) Antibody and what does it detect?

The Tri-Methyl-Histone H4 (Lys59) Antibody is a specific immunological reagent designed to recognize and bind to histone H4 proteins that contain a tri-methylation modification at the lysine 59 residue. This rabbit polyclonal antibody detects endogenous Histone H4 tri-methylated at Lys59, typically generated using a synthetic tri-methylated peptide corresponding to residues surrounding Lys59 of human histone H4 as the immunogen . The antibody provides researchers with a tool to investigate this specific histone modification in experimental contexts.

How does Tri-Methyl-Histone H4 (Lys59) differ from other histone H4 methylation marks?

While multiple lysine residues on histone H4 can undergo methylation, the tri-methylation at lysine 59 (H4K59me3) represents a distinct epigenetic modification with potentially unique functional consequences. Unlike the more extensively studied H4K20me3, which functions in chromatin structure, cell cycle regulation, DNA repair, and development , the specific biological functions of H4K59me3 are still being elucidated. Each histone modification creates a unique "mark" that can be recognized by specific reader proteins, leading to distinct downstream effects on chromatin structure and gene expression.

What validated applications exist for Tri-Methyl-Histone H4 (Lys59) Antibody?

The primary validated application for Tri-Methyl-Histone H4 (Lys59) Antibody is Western blotting (WB) . Similar to other histone modification antibodies, it likely can be adapted for additional techniques commonly employed in epigenetic research, including chromatin immunoprecipitation (ChIP), immunofluorescence (IF), and enzyme-linked immunosorbent assay (ELISA), though specific validation for these applications should be performed by researchers. The antibody has demonstrated reactivity with human, rat, and mouse samples .

How should researchers optimize Western blot protocols for Tri-Methyl-Histone H4 (Lys59) detection?

For optimal Western blot detection of H4K59me3, researchers should:

• Sample preparation: Extract histones using specialized acid extraction protocols to enrich for basic histone proteins.

• Gel electrophoresis: Use 15-18% SDS-PAGE gels to effectively resolve the low molecular weight (14 kDa) histone H4 protein .

• Transfer conditions: Implement longer transfer times or specialized transfer buffers containing SDS to ensure efficient transfer of basic histone proteins.

• Blocking: Use 5% BSA rather than milk-based blocking agents to prevent non-specific binding.

• Antibody dilution: Begin with manufacturer-recommended dilutions (typically 1:1000) and optimize as needed.

• Controls: Include both positive controls (extracts from cells known to contain H4K59me3) and negative controls (unmodified histone H4 or competing peptides).

Validation can be performed using sodium butyrate treatment of cells, which alters histone modification patterns, similar to protocols used for other histone modification analyses .

What methods can be used to validate the specificity of Tri-Methyl-Histone H4 (Lys59) Antibody?

Validating antibody specificity is crucial for reliable research outcomes. Researchers should consider:

• Peptide competition assays: Pre-incubating the antibody with increasing amounts of the immunogenic peptide (tri-methylated at K59) should progressively reduce signal intensity.

• Cross-reactivity assessment: Test against other methylated forms (mono- and di-methylated K59) and other methylated lysines on H4.

• Knockout/knockdown validation: Use genetic approaches to reduce or eliminate the enzyme responsible for H4K59 tri-methylation.

• Mass spectrometry correlation: Compare antibody-based detection with mass spectrometry analysis of histone modifications.

• Dot blot analysis: Test antibody recognition against a panel of modified and unmodified histone peptides.

Recent studies have revealed that some histone antibodies may preferentially recognize patterns of multiple modifications rather than single sites , underscoring the importance of rigorous validation.

What are the recommended storage and handling procedures for maintaining antibody activity?

To maintain optimal activity of Tri-Methyl-Histone H4 (Lys59) Antibody:

• Storage temperature: Store at -20°C as recommended by suppliers .

• Aliquoting: Upon receipt, prepare small working aliquots to minimize freeze-thaw cycles.

• Buffer composition: The antibody is typically supplied in a formulation containing glycerol (50%) and sodium azide (0.02%) as preservatives .

• Thawing procedure: Thaw aliquots on ice and centrifuge briefly before use to collect contents.

• Working dilutions: Prepare fresh working dilutions on the day of use when possible.

• Contamination prevention: Use sterile technique when handling to prevent microbial contamination.

Proper storage and handling significantly impact experimental reproducibility and antibody longevity.

How can researchers accurately quantify Tri-Methyl-Histone H4 (Lys59) levels from immunoblot data?

Accurate quantification requires:

• Normalization strategy: Normalize H4K59me3 signal to total histone H4 levels using a separate antibody against unmodified regions of H4.

• Linear detection range: Perform standard curve analysis to ensure signal detection falls within the linear range of the assay.

• Image acquisition: Use digital imaging systems with appropriate exposure settings to prevent saturation.

• Software analysis: Employ densitometry software with background subtraction capabilities.

• Statistical approach: Apply appropriate statistical methods when comparing multiple samples or conditions.

Note: This table provides general expectations based on patterns observed with similar histone modifications. Actual values will vary by experimental context and cell type.

What potential artifacts should researchers be aware of when interpreting Tri-Methyl-Histone H4 (Lys59) Antibody results?

Several factors can lead to misinterpretation:

• Epitope masking: Adjacent modifications may sterically hinder antibody binding, leading to false negatives.

• Cross-reactivity: Antibodies may recognize similar methylated lysine residues on H4 or other histones.

• Poly-modification preference: Recent research suggests that some histone antibodies preferentially recognize chromatin signatures with multiple adjacent modified residues rather than single modifications .

• Sample preparation artifacts: Acid extraction methods may differentially extract various modified histones.

• Biological variation: Modification levels can vary significantly between cell types, differentiation states, and cell cycle phases.

Researchers should incorporate multiple technical approaches and appropriate controls to mitigate these potential artifacts.

How can ChIP-seq be optimized for genome-wide mapping of H4K59me3 distribution?

For successful ChIP-seq applications:

• Chromatin preparation: Optimize sonication conditions to generate 200-500 bp fragments.

• Antibody amount: Typically 2-5 μg per ChIP reaction, but should be empirically determined.

• Controls:

  • Input chromatin (pre-immunoprecipitation)

  • IgG control for non-specific binding

  • Spike-in normalization for quantitative comparisons

• Sequencing depth: Minimum 20 million uniquely mapped reads per sample.

• Data analysis: Use specialized peak-calling algorithms suitable for histone modifications rather than transcription factor binding sites.

• Validation: Confirm selected loci by ChIP-qPCR before sequencing.

Recent advances in CUT&RUN or CUT&Tag methodologies may offer advantages over traditional ChIP-seq for histone modification profiling, including lower cell input requirements and improved signal-to-noise ratios.

How does the conformation of the histone H4 tail influence antibody accessibility to the K59me3 modification?

Research on histone H4 tail dynamics reveals:

• Conformational changes: Histone tails undergo significant conformational changes in response to modifications. Studies show that acetylation of histone H4 leads to tail compaction , which could potentially impact the accessibility of other modifications like K59me3.

• Chemical environment alterations: Modifications significantly alter the chemical environment of neighboring residues , potentially affecting antibody recognition efficiency.

• Inter-nucleosomal interactions: The H4 tail participates in contacts with adjacent nucleosomes, and these interactions may mask epitopes under certain conditions.

• Reader protein competition: Endogenous reader proteins bound to H4K59me3 in vivo may compete with antibody binding sites during experimental procedures.

NMR studies and structural analyses suggest that the H4 tail adopts multiple conformations in solution, with the probability distribution shifting toward more compact conformers when acetylated . Similar conformational changes might occur with methylation, potentially impacting experimental detection.

What is the relationship between H4K59me3 and other histone modifications in the context of the histone code?

The histone code hypothesis suggests that combinations of modifications create specific signatures recognized by reader proteins. For H4K59me3:

• Co-occurrence patterns: Research should investigate whether H4K59me3 typically co-occurs with, or is mutually exclusive with, other modifications on H4 (such as H4K20me3) or on other histones.

• Reader proteins: Similar to other histone methyl-lysine marks, H4K59me3 likely serves as a binding site for specific reader proteins containing methyl-lysine binding domains such as chromodomains, PHD fingers, or Tudor domains .

• Functional outcomes: The downstream effects may differ depending on neighboring modifications, similar to how the dual recognition of H3K4me3 and H3K27me3 by reader proteins creates bivalent chromatin domains with unique properties .

• Evolutionary conservation: Analysis of conservation across species can provide insights into functional importance.

Understanding these relationships requires integrative approaches combining ChIP-seq for multiple modifications, proteomics to identify reader proteins, and functional genomics to determine biological outcomes.

What are common causes of weak or absent signal when using Tri-Methyl-Histone H4 (Lys59) Antibody?

Common troubleshooting scenarios include:

• Low modification abundance: H4K59me3 may be present at low levels in some cell types or conditions.

• Epitope masking: Adjacent modifications may block antibody access.

• Extraction inefficiency: Incomplete histone extraction from chromatin.

• Antibody degradation: Improper storage leading to loss of activity.

• Protocol factors:

  • Insufficient blocking

  • Too stringent washing conditions

  • Suboptimal antibody concentration

  • Inappropriate secondary antibody

How can researchers distinguish between true H4K59me3 signal and potential cross-reactivity with other methylated lysines?

Distinguishing specific from non-specific signals requires:

• Peptide competition: Compare signal reduction with tri-methylated K59 peptide versus other methylated lysine peptides.

• Recombinant proteins: Test antibody against recombinant histone H4 with defined modifications.

• Knockout validation: Use cells lacking the enzyme responsible for H4K59 tri-methylation.

• Modified peptide arrays: Test antibody against arrays containing various histone modifications.

• Double labeling: Co-stain with antibodies against other histone marks and assess co-localization patterns.

Recent research has highlighted that histone modification antibodies may recognize patterns of modifications rather than single sites , making careful validation critical for accurate interpretation.